Foot Drop Treatment Devices Market Report 2025

This Foot Drop Treatment Devices market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The foot drop treatment devices market size has grown strongly in recent years. It will grow from $2.28 billion in 2024 to $2.47 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth observed during the historic period can be attributed to factors such as increased awareness about the availability of foot drop treatments, government healthcare initiatives aimed at improving access to assistive devices, a rising demand for non-invasive and comfortable treatment options, improvements in healthcare infrastructure, and a growing incidence of traumatic brain injuries.

The foot drop treatment devices market size is expected to see strong growth in the next few years. It will grow to $3.38 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth expected during the forecast period can be attributed to factors such as the increasing prevalence of neurological disorders, a rising geriatric population, a growing number of stroke survivors requiring foot drop treatment devices, the expansion of home healthcare services, and a higher number of spinal cord injury patients facing foot drop issues. Key trends anticipated during this period include advancements in medical technology that improve foot drop treatment devices, the adoption of wearable devices for mobility support, technological innovations in functional electrical stimulation, the development of customizable and adjustable foot drop devices, and the expansion of rehabilitation programs.

The growing incidence of neurological disorders and injuries is anticipated to drive the expansion of the foot drop treatment devices market. Neurological disorders and injuries refer to conditions that impact the brain, spinal cord, and nerves, leading to impairments in motor skills, sensation, cognition, or behavior due to damage, disease, or degeneration of the nervous system. Factors contributing to the rise in these conditions include an aging population, increased awareness and diagnosis, lifestyle factors, environmental influences, and medical advancements that improve detection and treatment. Foot drop treatment devices are crucial for individuals affected by neurological disorders and injuries, as these conditions often impair the ability to lift the foot, making walking difficult and increasing the risk of falls. These devices provide essential support and stability, helping lift the foot and improving mobility, thus enhancing the quality of life. For example, in October 2023, the World Federation of Neurology, based in the UK, reported that over 40% of the global population is affected by some neurological condition, and this figure is expected to nearly double by 2050. As a result, the increasing prevalence of neurological disorders and injuries is fueling the growth of the foot drop treatment devices market.

Leading companies in the foot drop treatment devices market are concentrating on creating innovative solutions, such as wearable devices, that seamlessly integrate into daily life while providing ongoing health and activity tracking. Wearable devices are technology-based tools designed to be worn on or near the foot to monitor, support, or enhance foot function. For example, in March 2022, Cionic, a US-based neurotechnology firm, received FDA approval for its groundbreaking Neural Sleeve. This advanced device delivers functional electrical stimulation to support ankle dorsiflexion and plantarflexion, as well as knee flexion and extension. It is aimed at treating foot drop and muscle weakness caused by neurological conditions such as multiple sclerosis, stroke, cerebral palsy, and spinal cord injuries. By stimulating specific muscles, the Neural Sleeve improves movement and gait. The FDA approval was based on comprehensive multicenter trials that demonstrated significant improvements in gait for individuals with foot drop, highlighting the device's potential to transform the lives of those with neurological impairments.

In January 2024, OrthoPediatrics, a medical device company based in the US, acquired Boston Orthotics & Prosthetics for $22 million. This acquisition is anticipated to strengthen OrthoPediatrics' Specialty Bracing division, which specializes in non-surgical treatments for pediatric orthopedic conditions. Boston Orthotics & Prosthetics, also a US-based company, manufactures devices, including ankle-foot orthotics, to treat foot drop.

Major players in the foot drop treatment devices market are Cardinal Health Inc., Stryker Corporation, Henry Schein Inc., Smith & Nephew LLC, Ottobock, Hanger Inc., Ossur, Bauerfeind USA Inc., Breg Inc., B. Braun Melsungen AG, Trulife Ltd., Orthomerica Products Inc., Bioness Inc., Evolution Health Care Pvt. Ltd., Aspen Medical Products, Allard Inc., Footmaxx, ProCare, DJO Global Inc., ALIMCO, Saebo Inc., Axio Bionics LLC, Thrive Orthopedics, Turbomed Orthotics, and Accord Medical Products Private Limited.

North America was the largest region in the foot drop treatment devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in foot drop treatment devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the foot drop treatment devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Foot drop treatment devices are specialized medical aids designed to help individuals with foot drop, a condition characterized by difficulty lifting the front part of the foot, often caused by neurological or muscular disorders. These devices work by supporting the foot in an elevated position, preventing it from dragging or slapping during walking. The goal of foot drop treatment devices is to improve mobility, reduce the risk of falls, and enhance the quality of life for those affected by the condition.

The primary types of foot drop treatment devices include electrical stimulators and braces or splints. An electrical stimulator is a device that delivers electrical impulses to stimulate nerves or muscles. It is used to treat conditions such as neuropathy, muscle disorders, brain and spinal disorders, among others. These devices are commonly used in hospitals, ambulatory surgical centers, clinics, and home care settings.

The foot drop treatment devices market research report is one of a series of new reports that provides foot drop treatment devices market statistics, including foot drop treatment devices industry global market size, regional shares, competitors with a foot drop treatment devices market share, detailed foot drop treatment devices market segments, market trends and opportunities, and any further data you may need to thrive in the foot drop treatment devices industry. This foot drop treatment devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The foot drop treatment devices market consists of sales of ankle-foot orthoses, toe lift assist devices, exoskeletons for lower limb support, and foot drop shoe inserts. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.